Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.68 | N/A |
| PEG Ratio (TTM) | 0.11 | N/A |
| P/S Ratio (TTM) | 1.02 | N/A |
| P/B Ratio (TTM) | 0.78 | N/A |
| P/FCF Ratio (TTM) | -79.89 | N/A |
| Price to 5YR AVG Earnings Ratio | -12.15 | N/A |
| Price to 5YR AVG FCF Ratio | -62.65 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -14.63% | N/A |
| ROE (TTM) | -19.95% | N/A |
| Net Profit Margin (TTM) | -27.41% | N/A |
| ROIC 5YR AVG | -11.80% | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -46.42% | -369.88% | -1,010.98% |
| Revenue | 12.98% | 44.53% | 30.00% |
| Net Income | -49.22% | -450.92% | -1,076.65% |
| Cash Flow | -81.28% | -159.34% | 144.29% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.23 | N/A |
| Quick Ratio (TTM) | 3.23 | N/A |
| D/E Ratio (TTM) | 0.31 | N/A |
| Interest Coverage (TTM) | -4.67 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 0.57 | N/A |
| LTL to 5YR AVG FCF | -24.22 | N/A |
| Shares Outstanding Growth 5YR AVG | 8.95% | N/A |